The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Nicola Antonio Colabufo

Dipartimento Farmacochimico

Universita degli Studi di Bari

via Orabona 4

70125

Italy

[email]@*.uniba.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Dipartimento Farmacochimico, Universita degli Studi di Bari, via Orabona 4, 70125, Italy. 2001 - 2011

References

  1. Clinical Pharmacokinetic and Metabolism of PET Radiotracers for Imaging P-glycoprotein in Chemoresistant Tumor of Colorectal Cancer. Cantore, M., Capparelli, E., Berardi, F., Perrone, R., Colabufo, N.A. Curr. Drug Metab. (2011) [Pubmed]
  2. EGFR tyrosine kinase inhibitors and multidrug resistance: perspectives. Colabufo, N.A., Contino, M., Niso, M., Berardi, F., Leopoldo, M., Perrone, R. Front. Biosci. (2011) [Pubmed]
  3. A new generation of MDR modulating agents with dual activity: P-gp inhibitor and iNOS inducer agents. Colabufo, N.A., Contino, M., Berardi, F., Perrone, R., Panaro, M.A., Cianciulli, A., Mitolo, V., Azzariti, A., Quatrale, A., Paradiso, A. Toxicol. In. Vitro (2011) [Pubmed]
  4. Substrates, inhibitors and activators of P-glycoprotein: candidates for radiolabeling and imaging perspectives. Colabufo, N.A., Berardi, F., Perrone, M.G., Capparelli, E., Cantore, M., Inglese, C., Perrone, R. Curr. Top. Med. Chem (2010) [Pubmed]
  5. Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases: pharmaceutical, biological, and diagnostic potentials. Colabufo, N.A., Berardi, F., Cantore, M., Contino, M., Inglese, C., Niso, M., Perrone, R. J. Med. Chem. (2010) [Pubmed]
  6. Multi-drug-resistance-reverting agents: 2-aryloxazole and 2-arylthiazole derivatives as potent BCRP or MRP1 inhibitors. Colabufo, N.A., Berardi, F., Perrone, M.G., Cantore, M., Contino, M., Inglese, C., Niso, M., Perrone, R. ChemMedChem (2009) [Pubmed]
  7. ABC pumps and their role in active drug transport. Colabufo, N.A., Berardi, F., Contino, M., Niso, M., Perrone, R. Curr. Top. Med. Chem (2009) [Pubmed]
  8. In vitro and ex vivo characterization of sigma-1 and sigma-2 receptors: agonists and antagonists in biological assays. Colabufo, N.A., Contino, M., Inglese, C., Niso, M., Perrone, R., Roperto, S., Roperto, F. Cent. Nerv. Syst. Agents. Med. Chem (2009) [Pubmed]
  9. Effect of some P-glycoprotein modulators on Rhodamine-123 absorption in guinea-pig ileum. Colabufo, N.A., Berardi, F., Contino, M., Inglese, C., Niso, M., Perrone, R. Bioorg. Med. Chem. Lett. (2008) [Pubmed]
  10. 2-[(3-Methoxyphenylethyl)phenoxy]-based ABCB1 inhibitors: effect of different basic side-chains on their biological properties. Colabufo, N.A., Berardi, F., Perrone, R., Rapposelli, S., Digiacomo, M., Vanni, M., Balsamo, A. J. Med. Chem. (2008) [Pubmed]
  11. 4-Biphenyl and 2-naphthyl substituted 6,7-dimethoxytetrahydroisoquinoline derivatives as potent P-gp modulators. Colabufo, N.A., Berardi, F., Cantore, M., Perrone, M.G., Contino, M., Inglese, C., Niso, M., Perrone, R., Azzariti, A., Simone, G.M., Paradiso, A. Bioorg. Med. Chem. (2008) [Pubmed]
  12. Tritium radiolabelling of PB28, a potent sigma-2 receptor ligand: pharmacokinetic and pharmacodynamic characterization. Colabufo, N.A., Abate, C., Contino, M., Inglese, C., Ferorelli, S., Berardi, F., Perrone, R. Bioorg. Med. Chem. Lett. (2008) [Pubmed]
  13. Synthesis and biological evaluation of (hetero)arylmethyloxy- and arylmethylamine-phenyl derivatives as potent P-glycoprotein modulating agents. Colabufo, N.A., Berardi, F., Perrone, R., Rapposelli, S., Digiacomo, M., Vanni, M., Balsamo, A. J. Med. Chem. (2008) [Pubmed]
  14. Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives. Colabufo, N.A., Berardi, F., Cantore, M., Perrone, M.G., Contino, M., Inglese, C., Niso, M., Perrone, R., Azzariti, A., Simone, G.M., Porcelli, L., Paradiso, A. Bioorg. Med. Chem. (2008) [Pubmed]
  15. Bicalutamide failure in prostate cancer treatment: involvement of Multi Drug Resistance proteins. Colabufo, N.A., Pagliarulo, V., Berardi, F., Contino, M., Inglese, C., Niso, M., Ancona, P., Albo, G., Pagliarulo, A., Perrone, R. Eur. J. Pharmacol. (2008) [Pubmed]
  16. PB183, a sigma receptor ligand, as a potential PET probe for the imaging of prostate adenocarcinoma. Colabufo, N.A., Abate, C., Contino, M., Inglese, C., Niso, M., Berardi, F., Perrone, R. Bioorg. Med. Chem. Lett. (2008) [Pubmed]
  17. Human epididymal and prostatic tracts of vas deferens: different contraction response to noradrenaline stimulation in isolated organ bath assay. Colabufo, N.A., Pagliarulo, V., Berardi, F., Contino, M., Perrone, R., Niso, M., Albo, G., de Rienzo, G., Pagliarulo, A. Eur. J. Pharmacol. (2007) [Pubmed]
  18. Correlation between sigma2 receptor protein expression and histopathologic grade in human bladder cancer. Colabufo, N.A., Berardi, F., Contino, M., Ferorelli, S., Niso, M., Perrone, R., Pagliarulo, A., Saponaro, P., Pagliarulo, V. Cancer Lett. (2006) [Pubmed]
  19. Is the sigma2 receptor a histone binding protein?. Colabufo, N.A., Berardi, F., Abate, C., Contino, M., Niso, M., Perrone, R. J. Med. Chem. (2006) [Pubmed]
  20. Arylmethyloxyphenyl derivatives: small molecules displaying P-glycoprotein inhibition. Colabufo, N.A., Berardi, F., Perrone, R., Rapposelli, S., Digiacomo, M., Balsamo, A. J. Med. Chem. (2006) [Pubmed]
  21. Distribution of sigma receptors in EMT-6 cells: preliminary biological evaluation of PB167 and potential for in-vivo PET. Colabufo, N.A., Berardi, F., Contino, M., Fazio, F., Matarrese, M., Moresco, R.M., Niso, M., Perrone, R., Tortorella, V. J. Pharm. Pharmacol. (2005) [Pubmed]
  22. Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines. Colabufo, N.A., Berardi, F., Contino, M., Niso, M., Abate, C., Perrone, R., Tortorella, V. Naunyn Schmiedebergs Arch. Pharmacol. (2004) [Pubmed]
  23. A new method for evaluating sigma(2) ligand activity in the isolated guinea-pig bladder. Colabufo, N.A., Berardi, F., Contino, M., Perrone, R., Tortorella, V. Naunyn Schmiedebergs Arch. Pharmacol. (2003) [Pubmed]
  24. Determination of dopamine D(4) receptor density in rat striatum using PB12 as a probe. Colabufo, N.A., Berardi, F., Calò, R., Leopoldo, M., Perrone, R., Tortorella, V. Eur. J. Pharmacol. (2001) [Pubmed]
 
WikiGenes - Universities